Expert Perspectives on the Utility of Real-World Data in the Management of Plaque Psoriasis - Episode 7
IL-23 inhibitors for Plaque Psoriasis Treatment
Published on:
Dermatology experts provide an overview of tildrakizumab, guselkumab, and risankizumab, agents approved for patients with plaque psoriasis.
